Presight Capital

Presight Capital is a global venture capital firm founded in 2019 by entrepreneur Christian Angermayer. Headquartered in West Hollywood, California, it manages over $600 million across seed-to-IPO stages, backed by prominent hedge fund managers and billionaire angels. The firm is sector-agnostic but leans heavily into frontier science and deep tech, including biotech, psychedelics, brain-computer interfaces, fintech, and life extension. Its lean core team taps a broader support network for strategic guidance, co-investing, and founder connections globally. Notable investments include AbCellera and Compass Pathways, both of which went public, plus ATAI Life Sciences, Qonto, Alloy Therapeutics, and Blackrock Neurotech. Its limited partners include prominent hedge fund figures and billionaire angels rather than traditional institutions. Presight's typical check size ranges from $500K to over $100 million, and it often co-leads or partners on rounds rather than investing solo. Its investment criteria favor ambitious founders tackling transformative, sometimes controversial science that mainstream VCs tend to avoid.